The Human Dimension
Panel Session
Pavilion G, Conference Hall G1

Russian healthcare over the past century has been recognized as a global leader in many areas. More recently, the government has introduced the “Health” National Priority Project and regional modernization programmes. What have been the results of the recent reforms in the industry and what challenges remain? What institutional and managerial solutions could help Russia regain its reputation for setting global standards? What is the prognosis for the sector over the short and medium term?

Guzel Ulumbekova , President of the Board, Association of Medical Societies for Quality of Medical Care and Medical Education; Head, Higher School of Healthcare Organization and Management

Olivier Bosc , President, Chief Executive Officer, GE Healthcare Russia and CIS
Elena Brusilova , President, International Clinic MEDSI
Michael Warmuth , Executive Vice-President, Established Pharmaceuticals Division, Abbott Laboratories
Arman Voskerchyan , General Director in Russia, Belarus, Transcaucasia and Central Asia, Philips
Jens Deerberg-Wittram , Executive Director, The Boston Consulting Group
Alberto Colzi , Vice-President, Eastern Europe, Middle East, and Africa Operations, AbbVie
Rustem Mardanov , Prime Minister of the Government of the Republic of Bashkortostan
Arkadi Stolpner , Chairman of the Board of Directors, DTC IIBS
Natalya Khorova , Deputy Minister of Healthcare of the Russian Federation
Olivier Charmeil , Executive Vice President and General Manager, General Medicines and Emerging Markets, Sanofi

Zalim Balkizov , Official Representative, Association for Medical Education in Europe (AMEE)
Aleksandr Potapov , Director, N.N. Burdenko Research Institute of Neurosurgery
Nikolay Semenov , Chief Executive Officer, National Immunobiological Company


Key moments

Big data if we are able to treat them will drive the efficiency of healthcare system. It’s a goldmine to be able to better diagnose and treat patients.
Olivier Charmeil
Coalescence of professional medicine and consumer healthcare at the juncture of medical data and technologies will lead to individualization of treatment methods and growing involvement of the patient in managing their own health.
Arman Voskerchyan